AAFMAA Wealth Management & Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
AAFMAA Wealth Management & Trust's PPH Position: Q3 2026 in Review
AAFMAA Wealth Management & Trust reduced its VanEck Pharmaceutical ETF (PPH) stake by 41% in Q3 2026, selling an estimated $1.14M and leaving 14,463 shares worth $1.58M. The position accounts for 0.54% of the portfolio, ranked #35.
AAFMAA Wealth Management & Trust first reported a position in PPH in Q2 2024 and has held it in 10 quarters since. The position peaked at $3.82M in Q1 2025. 154 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- AAFMAA Wealth Management & Trust held 14,463 shares of VanEck Pharmaceutical ETF worth $1.58M as of Q3 2026.
- AAFMAA Wealth Management & Trust sold 10,258 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $1.14M.
- VanEck Pharmaceutical ETF made up 0.54% of AAFMAA Wealth Management & Trust's portfolio in Q3 2026, its #35 holding.
- AAFMAA Wealth Management & Trust first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 10 quarters since.
- AAFMAA Wealth Management & Trust's VanEck Pharmaceutical ETF position peaked at $3.82M in Q1 2025.
- 154 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on AAFMAA Wealth Management & Trust's 13F filing for Q3 2026, filed 14 Oct 2026.